Appalachian Regional Healthcare, Inc.

Hazard, Kentucky 41701

0 studies enrolling now · 3 studies all time

What they study most

Anticoagulation, Asthma, Atrial Fibrillation Rapid, Carcinoma, Non-Small-Cell Lung, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Diabetes and Its Complications, End of Life/Desires Only Medical Management, Gout Flare, Heart Failure, Hypertensive Urgency, Infections

Studies at this site

• Rural Hospital-Level Care at Home for Acutely Ill Adults — Completed
• ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients — Completed
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early